CA2332012A1 - Laminate for application onto an acceptor - Google Patents

Laminate for application onto an acceptor Download PDF

Info

Publication number: CA2332012A1
Authority: CA; Canada
Prior art keywords: layer; sheet; laminate according; laminate; layers
Prior art date: 1998-05-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002332012A

Other languages

English (en)

French (fr)

Inventor

Christian Von Falkenhausen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

LTS Lohmann Therapie Systeme AG

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-11

Filing date

1999-04-29

Publication date

1999-11-18

1999-04-29 Application filed by Individual filed Critical Individual

1999-11-18 Publication of CA2332012A1 publication Critical patent/CA2332012A1/en

Status Abandoned legal-status Critical Current

Links

239000010410 layer Substances 0.000 claims abstract description 155
239000011241 protective layer Substances 0.000 claims abstract description 7
239000004480 active ingredient Substances 0.000 claims description 45
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
230000001225 therapeutic effect Effects 0.000 claims description 10
238000000034 method Methods 0.000 claims description 8
230000008569 process Effects 0.000 claims description 8
230000001681 protective effect Effects 0.000 claims description 7
238000010030 laminating Methods 0.000 claims description 4
238000004080 punching Methods 0.000 claims description 4
230000009286 beneficial effect Effects 0.000 claims 1
230000000087 stabilizing effect Effects 0.000 claims 1
210000003491 skin Anatomy 0.000 description 49
239000011505 plaster Substances 0.000 description 10
239000000463 material Substances 0.000 description 9
239000000370 acceptor Substances 0.000 description 7
230000011218 segmentation Effects 0.000 description 7
239000004615 ingredient Substances 0.000 description 6
239000000126 substance Substances 0.000 description 5
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
230000008901 benefit Effects 0.000 description 4
230000006835 compression Effects 0.000 description 4
238000007906 compression Methods 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
239000000853 adhesive Substances 0.000 description 3
150000002148 esters Chemical class 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
230000035699 permeability Effects 0.000 description 3
230000009467 reduction Effects 0.000 description 3
KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
CNIIGCLFLJGOGP-UHFFFAOYSA-N 2-(1-naphthalenylmethyl)-4,5-dihydro-1H-imidazole Chemical compound C=1C=CC2=CC=CC=C2C=1CC1=NCCN1 CNIIGCLFLJGOGP-UHFFFAOYSA-N 0.000 description 2
239000004372 Polyvinyl alcohol Substances 0.000 description 2
230000003356 anti-rheumatic effect Effects 0.000 description 2
239000003435 antirheumatic agent Substances 0.000 description 2
238000005452 bending Methods 0.000 description 2
238000005520 cutting process Methods 0.000 description 2
GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
238000006073 displacement reaction Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
230000006870 function Effects 0.000 description 2
LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
210000003205 muscle Anatomy 0.000 description 2
230000010412 perfusion Effects 0.000 description 2
-1 pol.yurethanes Polymers 0.000 description 2
229920002451 polyvinyl alcohol Polymers 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
230000002035 prolonged effect Effects 0.000 description 2
AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 2
230000003319 supportive effect Effects 0.000 description 2
NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
DBGIVFWFUFKIQN-UHFFFAOYSA-N (+-)-Fenfluramine Chemical compound CCNC(C)CC1=CC=CC(C(F)(F)F)=C1 DBGIVFWFUFKIQN-UHFFFAOYSA-N 0.000 description 1
SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
IGLYMJRIWWIQQE-QUOODJBBSA-N (1S,2R)-2-phenylcyclopropan-1-amine (1R,2S)-2-phenylcyclopropan-1-amine Chemical compound N[C@H]1C[C@@H]1C1=CC=CC=C1.N[C@@H]1C[C@H]1C1=CC=CC=C1 IGLYMJRIWWIQQE-QUOODJBBSA-N 0.000 description 1
TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 description 1
SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
IVQOFBKHQCTVQV-UHFFFAOYSA-N 2-hydroxy-2,2-diphenylacetic acid 2-(diethylamino)ethyl ester Chemical compound C=1C=CC=CC=1C(O)(C(=O)OCCN(CC)CC)C1=CC=CC=C1 IVQOFBKHQCTVQV-UHFFFAOYSA-N 0.000 description 1
XJBOZKOSICCONT-UHFFFAOYSA-N 4,6,6-trimethylbicyclo[3.1.1]hept-2-ene Chemical compound CC1C=CC2C(C)(C)C1C2 XJBOZKOSICCONT-UHFFFAOYSA-N 0.000 description 1
229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
229930003347 Atropine Natural products 0.000 description 1
239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
241001503987 Clematis vitalba Species 0.000 description 1
NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
229940123907 Disease modifying antirheumatic drug Drugs 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
239000013032 Hydrocarbon resin Substances 0.000 description 1
RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
102000010909 Monoamine Oxidase Human genes 0.000 description 1
108010062431 Monoamine oxidase Proteins 0.000 description 1
STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
239000000006 Nitroglycerin Substances 0.000 description 1
PIJVFDBKTWXHHD-UHFFFAOYSA-N Physostigmine Natural products C12=CC(OC(=O)NC)=CC=C2N(C)C2C1(C)CCN2C PIJVFDBKTWXHHD-UHFFFAOYSA-N 0.000 description 1
ATTZFSUZZUNHBP-UHFFFAOYSA-N Piperonyl sulfoxide Chemical compound CCCCCCCCS(=O)C(C)CC1=CC=C2OCOC2=C1 ATTZFSUZZUNHBP-UHFFFAOYSA-N 0.000 description 1
229920002367 Polyisobutene Polymers 0.000 description 1
239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
235000014443 Pyrus communis Nutrition 0.000 description 1
206010038776 Retching Diseases 0.000 description 1
239000000219 Sympatholytic Substances 0.000 description 1
GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
241000534944 Thia Species 0.000 description 1
241001319955 Unda Species 0.000 description 1
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
229930003427 Vitamin E Natural products 0.000 description 1
230000009471 action Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
150000001298 alcohols Chemical class 0.000 description 1
230000004075 alteration Effects 0.000 description 1
229940124326 anaesthetic agent Drugs 0.000 description 1
230000003444 anaesthetic effect Effects 0.000 description 1
229940035676 analgesics Drugs 0.000 description 1
239000003098 androgen Substances 0.000 description 1
229940030486 androgens Drugs 0.000 description 1
239000000730 antalgic agent Substances 0.000 description 1
229940125715 antihistaminic agent Drugs 0.000 description 1
239000000739 antihistaminic agent Substances 0.000 description 1
RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
229960000396 atropine Drugs 0.000 description 1
229960001498 benactyzine Drugs 0.000 description 1
230000002457 bidirectional effect Effects 0.000 description 1
229920001400 block copolymer Polymers 0.000 description 1
229960000330 bupranolol Drugs 0.000 description 1
HQIRNZOQPUAHHV-UHFFFAOYSA-N bupranolol Chemical compound CC1=CC=C(Cl)C(OCC(O)CNC(C)(C)C)=C1 HQIRNZOQPUAHHV-UHFFFAOYSA-N 0.000 description 1
MTAZNLWOLGHBHU-UHFFFAOYSA-N butadiene-styrene rubber Chemical compound C=CC=C.C=CC1=CC=CC=C1 MTAZNLWOLGHBHU-UHFFFAOYSA-N 0.000 description 1
DLNKOYKMWOXYQA-IONNQARKSA-N cathine Chemical compound C[C@H](N)[C@@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-IONNQARKSA-N 0.000 description 1
230000008859 change Effects 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
229960001076 chlorpromazine Drugs 0.000 description 1
230000001713 cholinergic effect Effects 0.000 description 1
229960002881 clemastine Drugs 0.000 description 1
YNNUSGIPVFPVBX-NHCUHLMSSA-N clemastine Chemical compound CN1CCC[C@@H]1CCO[C@@](C)(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 YNNUSGIPVFPVBX-NHCUHLMSSA-N 0.000 description 1
230000001447 compensatory effect Effects 0.000 description 1
239000000824 cytostatic agent Substances 0.000 description 1
230000001085 cytostatic effect Effects 0.000 description 1
KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
229960003529 diazepam Drugs 0.000 description 1
AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
150000001993 dienes Chemical class 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
HESHRHUZIWVEAJ-JGRZULCMSA-N dihydroergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2[C@@H](C3=CC=CC4=NC=C([C]34)C2)C1)C)C1=CC=CC=C1 HESHRHUZIWVEAJ-JGRZULCMSA-N 0.000 description 1
229960004704 dihydroergotamine Drugs 0.000 description 1
125000004925 dihydropyridyl group Chemical group N1(CC=CC=C1)* 0.000 description 1
229960000520 diphenhydramine Drugs 0.000 description 1
DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 1
239000003814 drug Substances 0.000 description 1
229920001971 elastomer Polymers 0.000 description 1
229960002179 ephedrine Drugs 0.000 description 1
239000000262 estrogen Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
229960001582 fenfluramine Drugs 0.000 description 1
229960002428 fentanyl Drugs 0.000 description 1
IVLVTNPOHDFFCJ-UHFFFAOYSA-N fentanyl citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 IVLVTNPOHDFFCJ-UHFFFAOYSA-N 0.000 description 1
239000012530 fluid Substances 0.000 description 1
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
229960003711 glyceryl trinitrate Drugs 0.000 description 1
229960003878 haloperidol Drugs 0.000 description 1
229920006270 hydrocarbon resin Polymers 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
229960000905 indomethacin Drugs 0.000 description 1
238000009413 insulation Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
210000003127 knee Anatomy 0.000 description 1
229960004194 lidocaine Drugs 0.000 description 1
235000001510 limonene Nutrition 0.000 description 1
229940087305 limonene Drugs 0.000 description 1
239000007788 liquid Substances 0.000 description 1
OXROWJKCGCOJDO-JLHYYAGUSA-N lornoxicam Chemical compound O=C1C=2SC(Cl)=CC=2S(=O)(=O)N(C)\C1=C(\O)NC1=CC=CC=N1 OXROWJKCGCOJDO-JLHYYAGUSA-N 0.000 description 1
229960002202 lornoxicam Drugs 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
229940041616 menthol Drugs 0.000 description 1
229960005016 naphazoline Drugs 0.000 description 1
229960002715 nicotine Drugs 0.000 description 1
SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
229940005483 opioid analgesics Drugs 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
230000035515 penetration Effects 0.000 description 1
239000000825 pharmaceutical preparation Substances 0.000 description 1
229940127557 pharmaceutical product Drugs 0.000 description 1
150000002990 phenothiazines Chemical class 0.000 description 1
PIJVFDBKTWXHHD-HIFRSBDPSA-N physostigmine Chemical compound C12=CC(OC(=O)NC)=CC=C2N(C)[C@@H]2[C@@]1(C)CCN2C PIJVFDBKTWXHHD-HIFRSBDPSA-N 0.000 description 1
229960001697 physostigmine Drugs 0.000 description 1
229960002702 piroxicam Drugs 0.000 description 1
QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
239000004014 plasticizer Substances 0.000 description 1
229920002587 poly(1,3-butadiene) polymer Polymers 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920000098 polyolefin Polymers 0.000 description 1
229920000915 polyvinyl chloride Polymers 0.000 description 1
239000004800 polyvinyl chloride Substances 0.000 description 1
239000002243 precursor Substances 0.000 description 1
239000000583 progesterone congener Substances 0.000 description 1
229960003712 propranolol Drugs 0.000 description 1
150000003180 prostaglandins Chemical class 0.000 description 1
230000009993 protective function Effects 0.000 description 1
229920005989 resin Polymers 0.000 description 1
239000011347 resin Substances 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
239000011435 rock Substances 0.000 description 1
229960002052 salbutamol Drugs 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
229930195734 saturated hydrocarbon Natural products 0.000 description 1
STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
229960002646 scopolamine Drugs 0.000 description 1
MEZLKOACVSPNER-GFCCVEGCSA-N selegiline Chemical compound C#CCN(C)[C@H](C)CC1=CC=CC=C1 MEZLKOACVSPNER-GFCCVEGCSA-N 0.000 description 1
229960003946 selegiline Drugs 0.000 description 1
229920005573 silicon-containing polymer Polymers 0.000 description 1
210000002460 smooth muscle Anatomy 0.000 description 1
239000007787 solid Substances 0.000 description 1
210000000434 stratum corneum Anatomy 0.000 description 1
239000000758 substrate Substances 0.000 description 1
229960004739 sufentanil Drugs 0.000 description 1
GGCSSNBKKAUURC-UHFFFAOYSA-N sufentanil Chemical compound C1CN(CCC=2SC=CC=2)CCC1(COC)N(C(=O)CC)C1=CC=CC=C1 GGCSSNBKKAUURC-UHFFFAOYSA-N 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
230000000948 sympatholitic effect Effects 0.000 description 1
230000009897 systematic effect Effects 0.000 description 1
229960000351 terfenadine Drugs 0.000 description 1
150000003505 terpenes Chemical class 0.000 description 1
235000007586 terpenes Nutrition 0.000 description 1
229960004605 timolol Drugs 0.000 description 1
229960003741 tranylcypromine Drugs 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
210000000689 upper leg Anatomy 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
235000005282 vitamin D3 Nutrition 0.000 description 1
239000011647 vitamin D3 Substances 0.000 description 1
229940046009 vitamin E Drugs 0.000 description 1
235000019165 vitamin E Nutrition 0.000 description 1
239000011709 vitamin E Substances 0.000 description 1
229940021056 vitamin d3 Drugs 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B7/00—Layered products characterised by the relation between layers; Layered products characterised by the relative orientation of features between layers, or by the relative values of a measurable parameter between layers, i.e. products comprising layers having different physical, chemical or physicochemical properties; Layered products characterised by the interconnection of layers
- B32B7/04—Interconnection of layers
- B32B7/06—Interconnection of layers permitting easy separation

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Dermatology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Birds (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)
Laminated Bodies (AREA)
Electroplating Methods And Accessories (AREA)

CA002332012A 1998-05-11 1999-04-29 Laminate for application onto an acceptor Abandoned CA2332012A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE19820999A DE19820999A1 (de)	1998-05-11	1998-05-11	Laminat zum Aufbringen auf einen Akzeptor
DE19820999.1		1998-05-11
PCT/EP1999/002897 WO1999058089A1 (de)	1998-05-11	1999-04-29	Laminat zum aufbringen auf einen akzeptor

Publications (1)

Publication Number	Publication Date
CA2332012A1 true CA2332012A1 (en)	1999-11-18

Family

ID=7867359

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002332012A Abandoned CA2332012A1 (en)	1998-05-11	1999-04-29	Laminate for application onto an acceptor

Country Status (16)

Country	Link
EP (1)	EP1077663A1 (no)
JP (1)	JP2002514523A (no)
KR (1)	KR20010071242A (no)
AU (1)	AU4035499A (no)
CA (1)	CA2332012A1 (no)
DE (1)	DE19820999A1 (no)
HU (1)	HUP0101825A2 (no)
ID (1)	ID26661A (no)
IL (1)	IL139510A0 (no)
NO (1)	NO20005731L (no)
PL (1)	PL344253A1 (no)
SK (1)	SK16952000A3 (no)
TR (1)	TR200003320T2 (no)
TW (1)	TW431897B (no)
WO (1)	WO1999058089A1 (no)
ZA (1)	ZA200006492B (no)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2017117554A1 (en) *	2015-12-30	2017-07-06	Corium International, Inc.	Systems and methods for long term transdermal administration
US11103463B2 (en)	2016-07-27	2021-08-31	Corium, Inc.	Methods for treating alzheimer's disease with donepezil transdermal system
US11173132B2 (en)	2017-12-20	2021-11-16	Corium, Inc.	Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
US11541018B2 (en)	2016-06-23	2023-01-03	Corium, Llc	Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10056014A1 (de) *	2000-11-11	2002-05-16	Beiersdorf Ag	Mehrschichtige Trägerkonstruktion für wirkstofhaltige Pflastersyteme
DE102010020050A1 (de) *	2010-05-11	2011-11-17	Ivf Hartmann Ag	Wundauflage
KR101160976B1 (ko) *	2010-07-19	2012-06-29	주식회사 글루칸	치주질환의 치료 또는 예방용 조성물
ES2878332T3 (es) *	2019-02-26	2021-11-18	Moelnlycke Health Care Ab	Proceso para introducir perforaciones en laminados que comprenden geles de silicona

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2340205A1 (de) *	1973-08-08	1975-02-20	Btr Industries Ltd	Wundverband
DE3634016A1 (de) *	1986-04-17	1987-10-29	Lohmann Gmbh & Co Kg	Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
DE8623009U1 (de) *	1986-08-28	1987-03-12	Lohmann Gmbh & Co Kg, 5450 Neuwied	Transdermales Pflaster
DE3714140A1 (de) *	1987-04-28	1988-11-10	Lohmann Therapie Syst Lts	Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut
DE3809978A1 (de) *	1988-03-24	1989-10-05	Lohmann Gmbh & Co Kg	Reservoir fuer gesteuerte wirkstoffabgabe, dieses enthaltende vorrichtung, sowie verfahren zu deren herstellung und verwendung der vorrichtung
DE3810658A1 (de) *	1988-03-29	1989-10-12	Lohmann Gmbh & Co Kg	Pflaster, insbesondere epikutantestpflaster und verfahren zur herstellung desselben
NL9100548A (nl) *	1991-03-27	1992-10-16	Nijverdal Ten Cate Textiel	Pleister met een voorraad medisch werkzame substantie.
DK5492A (da) *	1992-01-17	1993-07-18	Coloplast As	Hudpladeprodukt
EP0885603A3 (en) *	1993-09-17	1999-03-24	Nobutaka Tanaka	A method of manufacturing plasters
ATE206607T1 (de) *	1996-05-24	2001-10-15	Coloplast As	Dauerhaft deformierbarer verband

1998
- 1998-05-11 DE DE19820999A patent/DE19820999A1/de not_active Withdrawn
1999
- 1999-04-29 PL PL99344253A patent/PL344253A1/xx not_active Application Discontinuation
- 1999-04-29 IL IL13951099A patent/IL139510A0/xx unknown
- 1999-04-29 KR KR1020007012650A patent/KR20010071242A/ko not_active Withdrawn
- 1999-04-29 WO PCT/EP1999/002897 patent/WO1999058089A1/de not_active Ceased
- 1999-04-29 JP JP2000547941A patent/JP2002514523A/ja active Pending
- 1999-04-29 CA CA002332012A patent/CA2332012A1/en not_active Abandoned
- 1999-04-29 TR TR2000/03320T patent/TR200003320T2/xx unknown
- 1999-04-29 HU HU0101825A patent/HUP0101825A2/hu unknown
- 1999-04-29 ID IDW20002318A patent/ID26661A/id unknown
- 1999-04-29 AU AU40354/99A patent/AU4035499A/en not_active Abandoned
- 1999-04-29 SK SK1695-2000A patent/SK16952000A3/sk unknown
- 1999-04-29 EP EP99923493A patent/EP1077663A1/de not_active Withdrawn
- 1999-05-05 TW TW088107283A patent/TW431897B/zh active
2000
- 2000-11-09 ZA ZA200006492A patent/ZA200006492B/en unknown
- 2000-11-13 NO NO20005731A patent/NO20005731L/no not_active Application Discontinuation

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2016381351B2 (en) *	2015-12-30	2022-09-29	Corium, LLC.	Systems and methods for long term transdermal administration
US11648214B2 (en)	2015-12-30	2023-05-16	Corium, Llc	Systems and methods for long term transdermal administration
US10835499B2 (en)	2015-12-30	2020-11-17	Corium, Inc.	Systems and methods for long term transdermal administration
RU2737464C2 (ru) *	2015-12-30	2020-11-30	Кориум Интернэшнл, Инк.	Системы и способы длительного трансдермального введения
US10966936B2 (en)	2015-12-30	2021-04-06	Corium, Inc.	Systems comprising a composite backing and methods for long term transdermal administration
US12168075B2 (en)	2015-12-30	2024-12-17	Corium, Llc	Systems comprising a composite backing and methods for long term transdermal administration
CN108697655A (zh) *	2015-12-30	2018-10-23	考里安国际公司	用于长期透皮施药的系统和方法
US12161767B2 (en)	2015-12-30	2024-12-10	Corium, Llc	Systems and methods for long term transdermal administration
WO2017117554A1 (en) *	2015-12-30	2017-07-06	Corium International, Inc.	Systems and methods for long term transdermal administration
CN108697655B (zh) *	2015-12-30	2021-12-10	考里安公司	用于长期透皮施药的系统和方法
IL260290B2 (en) *	2015-12-30	2023-11-01	Corium Inc	Systems and methods for long-term percutaneous administration
US11679086B2 (en)	2015-12-30	2023-06-20	Corium, Llc	Systems comprising a composite backing and methods for long term transdermal administration
IL260290B1 (en) *	2015-12-30	2023-07-01	Corium Inc	Systems and methods for long-term percutaneous administration
US11541018B2 (en)	2016-06-23	2023-01-03	Corium, Llc	Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent
US11103463B2 (en)	2016-07-27	2021-08-31	Corium, Inc.	Methods for treating alzheimer's disease with donepezil transdermal system
US11173132B2 (en)	2017-12-20	2021-11-16	Corium, Inc.	Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point

Also Published As

Publication number	Publication date
JP2002514523A (ja)	2002-05-21
ZA200006492B (en)	2002-10-04
TW431897B (en)	2001-05-01
WO1999058089A1 (de)	1999-11-18
AU4035499A (en)	1999-11-29
EP1077663A1 (de)	2001-02-28
SK16952000A3 (sk)	2001-07-10
TR200003320T2 (tr)	2001-02-21
DE19820999A1 (de)	1999-11-18
ID26661A (id)	2001-01-25
NO20005731D0 (no)	2000-11-13
IL139510A0 (en)	2001-11-25
NO20005731L (no)	2000-11-13
PL344253A1 (en)	2001-10-22
KR20010071242A (ko)	2001-07-28
HUP0101825A2 (hu)	2001-10-28

Legal Events

Date	Code	Title	Description
2003-04-29	FZDE	Discontinued
2023-10-24	FZDE	Discontinued	Effective date: 20030429

Publication	Publication Date	Title
US8802136B2 (en)	2014-08-12	Transdermal patch incorporating active agent migration barrier layer
KR100483476B1 (ko)	2005-04-15	이중 점착제 경피 약물전달체계
EP2025310B1 (en)	2011-11-09	Patch and adhesive preparation
JP3924008B2 (ja)	2007-06-06	アンギオテンシン転換酵素（ａｃｅ）阻害剤を含有する経皮的に適用可能な薬剤
CZ20032813A3 (cs)	2004-08-18	Transdermální náplast pro podání fentanylu
SK278995B6 (sk)	1998-05-06	Spôsob kontinuálnej výroby transdermálnej terapeut
JP2004529890A (ja)	2004-09-30	活性成分としてのニコチンを有する可撓性の著しい皮膚透過性治療系
US20140242151A1 (en)	2014-08-28	Adhesive skin patch
CA2332012A1 (en)	1999-11-18	Laminate for application onto an acceptor
KR960005148B1 (ko)	1996-04-22	활성 물질의 국소적 또는 전신적 투여를 위한 약물의 단계 방출형 경피 투여 시스템
NZ207796A (en)	1987-07-31	Adhesive layered product for controlled release of active ingredients to skin
US5972376A (en)	1999-10-26	Transdermal system of tacrine/selegilin-plaster
MX2008009003A (es)	2008-11-12	Sistema terapeutico transdermico para sustancias volatiles y/o termolabiles.
HUP0003347A2 (hu)	2001-02-28	Transzdermális terápiás rendszer (TTS) hatóanyag leadásához és eljárás a bőrre történő alkalmazáshoz
BR112021009956A2 (pt)	2021-08-17	sistema terapêutico transdérmico, seu uso e seu processo de produção,kit que compreende pelo menos um sistema terapêutico transdérmico
CZ20004196A3 (cs)	2001-05-16	Laminát pro přiložení na akceptor
KR20010073008A (ko)	2001-07-31	3개의 기능 층을 갖는 약제 함유 플라스터
RU2246937C2 (ru)	2005-02-27	Система для чрескожного введения никотина
MXPA00011071A (en)	2002-05-09	Laminate for application onto an acceptor